相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preparation of 177Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A-DTPA as bifunctional chelators
Usha Pandey et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Technetium-99m-or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma
Ximena Carnacho et al.
ONCOLOGY (2017)
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents
Victoria Calzada et al.
Anti-Cancer Agents in Medicinal Chemistry (2016)
Evaluation of 177Lu-CHX-A-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers
Mythili Kameswaran et al.
APPLIED RADIATION AND ISOTOPES (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Synthesis and Preclinical Evaluation of 177Lu-CHX-A-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma
Mythili Kameswaran et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment
Sixiang Shi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
68Ga-Based Radiopharmaceuticals: Production and Application Relationship
Irina Velikyan
MOLECULES (2015)
99mTc carbonyl DTPA-Rituximab: Preparation and preliminary bioevaluation
Usha Pandey et al.
APPLIED RADIATION AND ISOTOPES (2014)
Past, present and future of 68Ge/68Ga generators
F. Roesch
APPLIED RADIATION AND ISOTOPES (2013)
Positron Emission Tomography Imaging of Tumor Angiogenesis with a 61/64Cu-Labeled F(ab′)2 Antibody Fragment
Hao Hong et al.
MOLECULAR PHARMACEUTICS (2013)
Optimization of IGF-1R SPECT/CT Imaging Using 111In-Labeled F(ab′)2 and Fab Fragments of Article the Monoclonal Antibody R1507
Sandra Heskamp et al.
MOLECULAR PHARMACEUTICS (2012)
In vitro and in vivo pre-clinical analysis of a F(ab')(2) fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
Karen J. Wong et al.
EJNMMI RESEARCH (2011)
Positive Progress in ImmunoPET-Not Just a Coincidence
Katelyn E. McCabe et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
PET versus SPECT: strengths, limitations and challenges
Arman Rahmim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas
Maroun Karam et al.
CANCER (2006)
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using In-111-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
分享论文
